4581大正製薬ホールディングス

Print Friendly, PDF & Email

市販薬最大手でドリンク剤、風邪薬、発毛剤が柱。医療用医薬品は骨粗鬆症薬主力。創業家色

会社サイト   株価   適時開示   大量保有報告書   有価証券報告書
有報(大正製薬)

開示年月日決算期種別連個実予売 上 高営業利益経常利益当期利益配当1Q2Q3Q
2006/05/152006/03年度271,40746,39549,74835,88430000
2006/05/152006/09中間131,000 22,50013,5000000
2006/11/092006/09中間121,97114,71716,42312,3290000
2006/05/152007/03年度266,000 45,50027,50027000
2007/05/152007/03年度242,07122,35724,92615,42027000
2007/05/152007/09中間119,00012,50014,5009,00000120
2007/11/072007/09中間120,71219,12422,45114,10500120
2007/05/152008/03年度240,50023,00028,50017,500270120
2008/05/142008/03年度249,65536,95241,89625,004270120
2008/07/292008/061Q61,85311,64412,3607,6930000
2008/05/142008/092Q124,00015,00016,5009,50000120
2008/10/172008/092Q126,00019,50020,500▲1,00000120
2008/10/292008/092Q126,31419,48320,757▲1,05300120
2009/01/292008/123Q199,79732,47934,1494,69500120
2008/05/142009/03年度252,00033,00037,50022,500270120
2008/10/172009/03年度252,00035,50039,00010,500270120
2009/01/292009/03年度255,00036,50037,5006,500270120
2009/04/302009/03年度256,20037,90039,9008,800270120
2009/05/152009/03年度256,21337,93539,9028,815270120
2009/07/312009/061Q63,5636,2567,0743,5800000
2009/05/152009/092Q126,00016,00017,0009,50000120
2009/07/312009/092Q128,00017,00018,00010,00000120
2009/10/302009/092Q129,75518,19918,85510,36400120
2010/01/292009/123Q202,93029,24530,64915,77400120
2009/05/152010/03年度257,00034,00039,00023,000270120
2009/10/302010/03年度262,00034,50036,00019,500270120
2010/01/292010/03年度259,00033,50035,50018,500270120
2010/05/142010/03年度258,44134,68636,67119,485270120
2010/07/302010/061Q64,55761,06170,09333,0730000
2010/05/142010/092Q129,50016,50018,00010,50000120
2010/10/072010/092Q133,00023,00025,00014,50000120
2010/10/292010/092Q133,04624,63526,83316,21900120
2011/01/312010/123Q207,72840,29243,62225,94600120
2010/05/142011/03年度262,00036,00040,50024,500270120
2010/10/072011/03年度265,50037,50041,50025,000270120
2010/10/292011/03年度265,50039,00043,00026,000270120
2011/01/312011/03年度265,50041,00045,00027,500270120
2011/04/202011/03年度268,50044,00054,00034,500270120
2011/05/132011/03年度268,63244,08254,07734,892270120
2011/07/292011/061Q64,26510,85112,5588,0520000
2011/05/132011/092Q136,50021,00023,50014,00000120
2011/10/122011/092Q132,50020,00022,50011,50000120
2011/10/312011/092Q133,16420,29823,45312,79600120
2012/02/022011/123Q211,19834,93941,10321,0140000
2011/05/132012/03年度274,00039,50045,50028,000未定0120
2011/10/032012/03年度274,00039,50045,50028,000未定000
2011/10/122012/03年度270,50036,50042,00024,500未定000
2011/10/312012/03年度275,05536,50042,00024,50050000
2012/02/022012/03年度270,50036,50043,50023,00050000
2012/05/112012/03年度271,32038,41246,20124,35750000
2012/07/312012/061Q67,7739,80712,1717,5910000
2012/05/112012/092Q135,50016,50019,50013,00000600
2012/07/312012/092Q139,00017,00020,00013,50000600
2012/10/312012/092Q139,95219,54623,67112,66600600
2013/01/312012/123Q220,26930,79537,92821,84800600
2012/05/112013/03年度278,50037,00044,00028,5001200600
2012/07/312013/03年度285,00037,50044,50029,0001200600
2012/10/312013/03年度287,00036,50044,50026,5001200600
2013/01/312013/03年度285,50035,50043,80026,5001200600
2013/05/102013/03年度285,16835,33744,17326,3201200600
2013/07/312013/061Q68,1789,04711,4847,4100000
2013/05/102013/092Q144,50020,50024,50015,00000500
2013/10/312013/092Q144,56321,50925,57516,51600500
2014/01/302013/123Q227,93936,46843,81627,83900500
2013/05/102014/03年度293,00039,50047,50030,0001100500
2013/10/312014/03年度294,50038,00046,50030,0001100500
2014/05/122014/03年度295,99741,68351,24432,6921100500
2014/07/312014/061Q68,3718,60710,7746,6580000
2014/05/122014/092Q147,00015,00019,00012,00000500
2014/10/312014/092Q141,80516,23119,58712,59300500
2015/01/302014/123Q221,75924,83530,89119,64000500
2014/05/122015/03年度299,00030,50038,50025,5001100500
2014/10/312015/03年度293,00029,00037,00024,0001100500
2015/01/302015/03年度290,50029,00037,00024,0001100500
2015/05/132015/03年度290,49831,97439,57624,5281100500
2015/07/302015/061Q69,2125,2347,4934,6860000
2015/05/132015/092Q144,00010,00014,0008,50000500
2015/10/202015/092Q146,00013,90017,70011,30000500
2015/10/302015/092Q145,98413,92517,68011,28100500
2016/02/032015/123Q224,97822,72229,09718,70500500
2015/05/132016/03年度295,00027,00035,00022,0001000500
2016/02/032016/03年度290,00027,00035,00021,5001000500
2016/05/162016/03年度290,13528,87836,77522,4731000500
2016/08/012016/061Q69,4319,10610,4226,9450000
2016/05/162016/092Q140,00011,00014,0009,00000500
2016/08/012016/092Q140,00013,00015,50010,00000500
2016/10/192016/092Q141,00016,70019,10013,50000500
2016/10/312016/092Q141,00716,65519,12913,49900500
2017/02/022016/123Q216,43126,56031,37623,67000500
2016/05/162017/03年度285,00029,50036,50024,0001100500
2017/02/022017/03年度281,50030,50036,50027,5001100500
2017/05/152017/03年度279,77331,96638,03628,7811100500
2017/08/022017/061Q68,5326,9418,7965,5340000
2017/05/152017/092Q137,50011,50014,50010,50000500
2017/10/252017/092Q138,60015,20017,90012,00000500
2017/10/302017/092Q138,63015,17817,85012,01600500
2018/02/012017/123Q215,79828,55533,37926,46300500
2017/05/152018/03年度279,00028,50034,50024,0001100500
2018/02/012018/03年度279,50033,50038,50030,0001100500
2018/05/142018/03年度280,09236,97742,14031,6791100500
2018/08/012018/061Q61,7488,15712,20513,6890000
2018/05/142018/092Q132,00014,00016,50039,00000500
2018/10/232018/092Q129,50017,00022,70042,40000500
2018/10/292018/092Q129,49116,99122,71042,43400500
2019/01/302018/123Q199,89628,11636,16351,39800500
2018/05/142019/03年度269,00033,00039,50055,5001100500
2019/01/302019/03年度261,50033,00042,50052,5001100500
2019/05/132019/03年度261,55131,21140,85148,5931200500
2019/07/292019/061Q60,2608,3247,64911,0060000
2019/05/132019/092Q126,50016,50020,00013,50000500
2019/07/292019/092Q131,00014,00014,50015,50000500
2019/10/302019/092Q132,20814,67614,97514,97900500
2020/02/142019/123Q211,33817,56920,97017,92900500
2019/05/132020/03年度253,50035,50042,50028,5001100500
2019/07/292020/03年度293,50033,00037,00029,5001100500
2020/02/142020/03年度290,50021,50026,00021,0001100500
2020/05/142020/03年度288,52721,46025,01020,5311100500
2020/08/052020/061Q75,0239,38911,1176,0640000
2020/05/142020/092Q非開示00500
2020/10/292020/092Q145,90016,29518,85911,29400500
2021/02/042020/123Q214,30020,86424,74214,23500500
2020/05/142021/03年度289,50020,00023,00013,0001000500
2021/02/042021/03年度283,00021,00025,50014,0001000500
2021/05/142021/03年度281,98019,96525,94613,3161000500
2021/05/142021/092Q非開示00500
2021/05/142022/03年度269,00014,50018,50010,5001000500

2011/10に株式移転により設立。同日前は大正製薬の計数。株式移転比率は1→0.3
2021/7に株式交換によりビオフェルミン製薬を完全子会社化

大正薬HD